Document is current
Any future updates will be listed below
-
Authors
Hoseini, Seyed Mehdi
Bahrami, Ahmad Reza
Kalantar, Seyed Mehdi
Sheikhha, Mohammad Hasan
Aflatoonian, Behrouz
Ghasemi, Nasrin
Hosseini, Elham Sadat
Matin, Maryam M.
Montazeri, Fateme
-
Funding
Funding for this research was provided by:
Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 8 May 2025
First Online: 3 January 2026
Declarations
:
: 1—Title of the approved project : Investigation of the Expression Level of Indoleamine 2,3-Dioxygenase (IDO) As an Immunosuppressive-Immunomodulatory Marker in Amniotic Fluid-Derived Mesenchymal Stem/Stromal Cells from Women Who Experienced Recurrent Pregnancy Loss.Name of the institutional approval committee: Research Ethics Committee of Shahid Sadoughi University of Medical Sciences (Specific Code: IR.SUU.REC ); approval number: IR.SSU.REC.1396.169 (official committee minutes number of 255339 for project 5664); approval date: 2018, January 9. 2—Title of the approved project : Investigation of Induced T-Regulatory Cells in Peripheral Blood Mononuclear Cells Cultured Under Conditioned Medium of Mesenchymal Stem/Stromal Cells Derived from Amniotic Fluid of Pregnant Women Who Experienced Idiopathic Recurrent Pregnancy Loss.Name of the institutional approval committee: Research Ethics Committee of Research Center for Infertility - Shahid Sadoughi University of Medical Sciences (Specific Code: IR.SUU.RSI.REC ); approval number: IR.SSU.RSI.REC.1399.041 (official committee minutes number of 320711 for project 10001); approval date: 2021, February 21.
: The authors declare no competing interests.
